Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 7/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3439705 | 1.00 | MDM4 (0.52) | MDM4TP53MDM2 | |
| SCHEMBL21474286 | 1.00 | MDM4 (0.52) | MDM4TP53MDM2 | |
| SCHEMBL13697504 | 1.00 | MDM4 (0.52) | MDM4TP53MDM2 | |
| SCHEMBL29386828 | 1.00 | MDM4 (0.52) | MDM4TP53MDM2 | |
| Cyclohexylamine SCHEMBL29401058 | 0.92 | MDM4 (0.48) | MDM4TP53MDM2 | |
| Cyclohexylamine SCHEMBL29401401 | 0.92 | MDM4 (0.48) | MDM4TP53MDM2 | |
| SCHEMBL29401227 | 0.92 | MDM4 (0.56) | MDM4TP53MDM2 | |
| SCHEMBL29368221 | 0.92 | MDM4 (0.56) | MDM4TP53MDM2 | |
| SCHEMBL1486207 | 0.92 | MDM4 (0.56) | MDM4TP53MDM2 | |
| SCHEMBL31382825 | 0.92 | MDM4 (0.46) | MDM4TP53MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119320430-A | Polypeptide PT-1509 and application thereof in antitumor drugs | 科通诺贝生物医药科技(北京)有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-118949004-B | Bioactive solution and application thereof | 天津医科大学 | 2025-01-14 | — | — | CN | disclosed |
| CN-119192297-A | Polypeptide crossing vascular endothelium and selectively anchoring HSCs and application thereof | 天津医科大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-119101127-A | Polypeptide for enhancing NK cell immune killing and inhibiting HSCs activation and application thereof | 天津医科大学 | 2024-12-10 | — | — | CN | disclosed |
| CN-118949004-A | Bioactive solution and application thereof | 天津医科大学 | 2024-11-15 | — | — | CN | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20230041996-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION THEREOF | BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| EP-4091623-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION THEREOF | Beijing Tuo Jie Biopharmaceutical Co. Ltd. (CN) | 2022-11-23 | — | — | EP | disclosed |
| CN-113072622-B | Polypeptide for selectively degrading PD-L1 protein on tumor cell membrane and application | 南开大学 | 2022-08-05 | — | — | CN | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |